Meatly plans London cultivated pet food facility for 2027: full analysis
Version 2
Meatly is trying to turn a one-store pilot into industrial-scale production. The London cultivated meat company has raised £10.4 million in Series A financing to build a 20,000-litre facility in London, which it says will be Europe’s largest cultivated meat production site, with product launches from the plant expected in 2027. The announcement matters because Meatly is not starting from zero: it already secured UK authorization for cultivated chicken in pet food in 2024 and followed that with a limited commercial launch in February 2025. (startup.eu)
That background is important. Cultivated meat companies have spent years promising scale, but many have struggled to move beyond pilot batches and investor presentations. Meatly’s earlier launch, done with dog food brand THE PACK and sold through a Pets at Home location in Brentford, gave the company a real-world retail proof point, even if volumes were small. On its website, Meatly says it aims to move from one-off releases to continuous store sales from 2027 onward, tying that commercial ambition directly to the new facility buildout. (meatly.pet)
The financing round appears designed to answer the sector’s central question: can cultivated protein be produced at meaningful volume and cost? Multiple reports say the new London site will center on a 20,000-litre bioreactor. Startup and trade coverage identified Oyster Bay Venture Capital, Clean Growth Fund, and JamJar Investments as new institutional investors, with Agronomics and Pets at Home remaining involved. Meatly has previously said it developed a protein-free growth medium costing less than £1 per litre, a claim it has used to argue that its route to market can be more cost efficient than many cultivated meat peers. (foodmanufacture.co.uk)
On regulation, the UK is becoming an important test case for cultivated pet food, but it is still a patchwork picture rather than a settled global standard. UK Pet Food says Meatly Chicken was, at the time of its factsheet, the only cell-cultivated product approved for use in pet food in the UK, and notes that these ingredients remain subject to the same Animal and Plant Health Agency inspection framework that applies to meat and animal by-products used in pet food. Separately, the Food Standards Agency and Food Standards Scotland have now published the UK’s first safety guidance for cell-cultivated products and are running a broader sandbox program to support future assessments. For veterinary teams, that means the science and oversight framework is getting more formal, but the market is still at a very early stage. (ukpetfood.org)
Industry reaction has been broadly optimistic, especially from organizations focused on alternative proteins and pet food innovation. Pets at Home framed the 2025 launch as part of its sustainability strategy, and THE PACK called the first retail release a turning point for the sector. Broader industry commentary has also pointed to pet food as a practical entry point for cultivated protein because it may face fewer consumer barriers than human food while still addressing concerns around livestock inputs, supply volatility, and environmental footprint. At the same time, consumer acceptance should not be taken for granted: an FSA evidence review found willingness to consume cell-cultivated meat in the UK remains mixed, which is relevant because pet parent attitudes will shape uptake even when the product is intended for animals, not people. (meatly.pet)
Why it matters: For veterinary professionals, cultivated pet food is moving closer to a practical client conversation. If companies like Meatly can scale supply, vets may start seeing more products positioned around sustainability, animal welfare, or supply-chain resilience. But those claims will land in exam rooms only if they are matched by clear evidence on nutrient profile, digestibility, palatability, quality control, and suitability for different life stages and disease states. There is also a communication challenge: UK regulators do not classify these products as “meat” in the legal sense used in food law, even though companies market them as cultivated meat, so labeling and client understanding may not always align neatly. (food.gov.uk)
What to watch: The next markers are straightforward but significant: facility fit-out and commissioning in London, any additional limited product releases before 2027, evidence that production costs are falling, and more public data to support nutritional and safety claims. It will also be worth watching whether Meatly stays focused on the UK or seeks broader European expansion, where the regulatory path for cultivated products remains more complex and less mature than its UK pet food precedent. (meatly.pet)